Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
DNA Replication Group, CNIO, 28029 Madrid, Spain.
Dev Cell. 2015 Jan 26;32(2):155-67. doi: 10.1016/j.devcel.2014.12.015.
Polyploidization is a natural process that frequently accompanies differentiation; its deregulation is linked to genomic instability and cancer. Despite its relevance, why cells select different polyploidization mechanisms is unknown. Here we report a systematic genetic analysis of endomitosis, a process in which megakaryocytes become polyploid by entering mitosis but aborting anaphase. Whereas ablation of the APC/C cofactor Cdc20 results in mitotic arrest and severe thrombocytopenia, lack of the kinases Aurora-B, Cdk1, or Cdk2 does not affect megakaryocyte polyploidization or platelet levels. Ablation of Cdk1 forces a switch to endocycles without mitosis, whereas polyploidization in the absence of Cdk1 and Cdk2 occurs in the presence of aberrant re-replication events. Importantly, ablation of these kinases rescues the defects in Cdc20 null megakaryocytes. These findings suggest that endomitosis can be functionally replaced by alternative polyploidization mechanisms in vivo and provide the cellular basis for therapeutic approaches aimed to discriminate mitotic and polyploid cells.
多倍体化是一个自然的过程,经常伴随着分化;其失调与基因组不稳定性和癌症有关。尽管如此,为什么细胞会选择不同的多倍体化机制还不清楚。在这里,我们报告了对核内有丝分裂(endomitosis)的系统遗传分析,这是一个巨核细胞通过进入有丝分裂但中止后期而成为多倍体的过程。虽然 APC/C 辅助因子 Cdc20 的缺失会导致有丝分裂停滞和严重的血小板减少症,但 Aurora-B、Cdk1 或 Cdk2 激酶的缺失不会影响巨核细胞的多倍体化或血小板水平。Cdk1 的缺失迫使细胞进入没有有丝分裂的内周期,而 Cdk1 和 Cdk2 缺失时的多倍体化则发生在异常的再复制事件存在的情况下。重要的是,这些激酶的缺失可以挽救 Cdc20 缺失的巨核细胞的缺陷。这些发现表明,在体内,有丝分裂和多倍体化细胞可以通过替代的多倍体化机制来替代,为旨在区分有丝分裂和多倍体细胞的治疗方法提供了细胞基础。